Thursday, August 12, 2010

Of No Import: Autism Bran Scan Study Excluded Subjects With Intellectual Disability

My Lords, view these letters full of bad mischance.
France is revolted from the English quite, 
Except some petty towns of no import

- The Second Messenger, The Fifth Part of King Henry VI, Act I, Scene I, William Shakespeare

The new MRI Bran Scan study   promises to be a major event with important consequences for diagnosis of autism disorders and  establishment of autism biomarkers. The results could affect our understanding of the nature of autism disorders, what causes them and ... who is, or is not, autistic.  Unfortunately the study, like so many other autism studies and discussions of autism disorders,  excluded those with intellectual disabilities.

It is common in public discussions of autism as reflected in Hollywood movies and major media institutions like CNN, CBC and the New Yorker, government institutions like the IACC, and autism advocacy groups like Autism Speaks and ASAN to talk about "autism" from the perspective of very high functioning persons with autism or Aspergers like Temple Grandin, Alex Plank, Ari Ne'eman, Jon Elder Robison, Amanda Baggs and Michelle Dawson.  Virtually no effort is made to discuss the realities of those very substantial number of persons with autism who are intellectually disabled,  those who constitute the "vast majority", as much as 75-80% of persons with Autistic Disorder.

Even in the  DSM-IV era with its broadly expanded definition of autism which includes all those with Aspergers who, by diagnostic definition, are not intellectually disabled, the total numbers of persons with intellectual disabilities  constitutes between 41-44% of all persons with Autism Spectrum Disorders of any type ... according to two recent CDC surveys. Yet many research projects purporting to study "autism" exclude from their subject pool persons with autism disorders and intellectual disabilities. The autism brain scan study by Ecker et al published in the August 11, 2010 edition of  the Journal of Neuroscience is no exception to this trend. It expressly excludes those persons with autistic disorder who are intellectually disabled:

"Participants. Twenty control adults were recruited locally by advertisement and 20 adults with ASD were recruited through a clinical research program at the Maudsley Hospital/Institute of Psychiatry (London). All volunteers (see Table 1) gave informed consent (as approved by the Institute of Psychiatry and Bethlem and Maudsley Hospital Trust research ethics committee), and had a full-scale intelligence quotient (FSIQ)>75 [WASI (Wechsler, 1999)]."
There may have been ethical and practical limitations which precluded the participation of  autistic subjects with intellectual disabilities. But it does not seem reasonable to this humble father of a 14 year old son with Autistic Disorder and intellectual disabilities to expressly exclude from a study of the brains of persons with "autism" such a large group of autistic persons distinguished in such an important way from those who are the subject participants in the study.  Notwithstanding the express exclusion of autistic participants with intellectual disabilities the study authors draw conclusions about persons with "Autism Spectrum Disorder":

"Discussion

Autism affects multiple aspects of the cerebral anatomy, which makes its neuroanatomical
correlates inherently difficult to describe. Here, we used a multiparameter classification approach to characterize the complex and subtle gray matter differences in adults with ASD.  SVM achieved good
separation between groups, and revealed spatially distributed and largely nonoverlapping patterns of regions with highest classification weights for each of five morphological features. Our results confirm that the neuroanatomy of ASD is truly multidimensional affecting multiple neural systems. The discriminating patterns detected using SVM may help further exploration of the genetic and neuropathological underpinnings of ASD."

It appears that Ecker et al, when drawing conclusions about the brains of persons with "Autism Spectrum Disorder" do not feel that the participation of subjects with "ASD" who are intellectually disabled is necessary, despite the large percentage of the Autism Spectrum that they comprise. It seems that when it comes to persons with autism disorders who are intellectually disabled Ecker et al are of the view that the fact of being autistic and intellectually disabled is of no import, that it is sufficient to categorize the various subtypes of autism spectrum disorder without actually looking at such a large and severely affected component of that spectrum.

Is the Ecker study a precursor of the New Autism Spectrum Disorder in the DSM5? Will those with Autism Spectrum Disorder and intellectual disabilities simply be excluded from autism diagnosis? It is obviously too early to draw such a conclusion but this study with its cavalier exclusion of intellectually disabled autistic subjects from an attempt to establish biomarkers for "autism" raises that possibility. Intellectually disabled autistic adults are largely hidden from society physically in institutions and from public awareness. as reflected in Hollywood and mainstream media portrayals of autism. They are now excluded from some important autism research. In the DSM5 exclusion from the "autism spectrum" itself may be the final result.

Wednesday, August 11, 2010

Autism Earthquake? The MRI Adult Autism Brain Scan Biomarker

Every day brings reports of new autism studies, most of which are of little or no obvious value, studies which show that a group of high functioning autism subjects are very intelligent, studies which show that some families of autistic children are relatively affluent, studies which purport to define an autistic "smile" and so on. 

News of a study which claims to have established, using MRI bran scans,  a biomarker for autism disorders is different.  An autism biomarker may  have profound and immediate impact on the very definition of autism as "Socrates" of the New Republic has already mentioned  in  Autism Diagnosis by MRI Brain Scan. Socrates gets right to the point while introducing a quote by one of the study authors Declan Murphy of King's College London:

"In an astonishing turn of events, the study due to be published later today, may throw into chaos the process for revising the DSM V definition of Autism.To date Autism has been defined solely on the basis of behaviour - a situation that is set to change radically.

I agree with Socrates. A reliable biomarker may throw the DSM5 autism revision process into chaos.  In my view the drafters of the New Autism Spectrum Disorder in the DSM5  would be wise to stay their autism revision efforts until it can be determined whether this study receives widespread acceptance in the autism research community. If the study results are deemed reliable as indicating biomarker(s) for autism disorders than the revision process should stop until the full implications of the study are determined. There seems to be little point in revising definitions of autism disorders based solely on behavioral characteristics just as reliable biomarkers are being established and defined.

There could be many significant impacts of a reliable autism biomarker.  The study authors speculate that the biomarker will help autistic people and their families by providing quicker, more cost effective diagnosis. I hope they are right.  Private and public treatment and service providers will undoubtedly move to incorporate the use of the biomarkers into their criteria for determining whether to provide treatment or services.  This could actually result in more waiting list delays for the scans which could  simply be added on to existing eligibility requirements for receipt of  services.

Current autism research conclusions including, possibly, epidemiological based vaccine research conducted during periods of changing definitions of autism in the DSM-IIII and IV, may have to be revisited using the new biomarkers. And of course some of the very high functioning persons currently diagnosed with Autism and Aspergers may lose their diagnostic labels ... and their careers as unelected,  self appointed spokespersons for  all "autistics". Debates about the use of functioning labels and differences of autism severity could become obsolete if clear biological/neurological distinctions are identified by MRI Brain Scans.


If  the study results are confirmed and accepted by the autism research community the autism world may have just felt the first preshock of an autism earthquake that will reshape the autism world. 

Information about the new MRI brain scan autism biomarker from the Medical Research Council:



Autism in adults diagnosed by quick, new brain scan

Tuesday 10 August, 2010

Scientists funded by the Medical Research Council (MRC) have  developed  a pioneering new method of diagnosing autism in adults. For the first time, a quick brain scan that takes just 15 minutes can identify adults with autism with over 90% accuracy. The method could lead to the screening for autism spectrum disorders in children in the future.

In the MRC-funded study, scientists at the Institute of Psychiatry (IoP), King’s College London, used an MRI scanner to take pictures of the brain’s grey matter. A separate imaging technique was then used to reconstruct these scans into 3D images that a computer algorithm can assess for structure, shape and thickness – all intricate measurements that reveal Autism Spectrum Disorder (ASD) at its root. Having developed this process, the computer can quickly pinpoint biological markers, rather than personality traits, to assess whether or not a person has ASD.

ASD is a lifelong and disabling condition caused by abnormalities in brain development. It affects about 1% of the UK population (over half a million people), the majority of these being men (4:1 male to female). Until now, diagnosis has mainly relied on personal accounts from friends or relatives close to the patient – a long and drawn-out process hinged on the reliability of this account and requiring a team of experts to interpret the information.

Dr Christine Ecker, a Lecturer in the Department of Forensic and Neurodevelopmental Sciences from the IoP, who carried out the study said:


“The value of this rapid and accurate tool to diagnose ASD is immense. It could help to alleviate the need for the emotional, time consuming and expensive diagnosis process which ASD patients and families currently have to endure. We now look forward to testing if our methods can also help children.”

Professor Declan Murphy, Professor of Psychiatry and Brain Maturation at the IoP, who led the research said:

“We think that our new method will help people with ASD to be diagnosed more quickly and cost effectively. Most importantly their diagnosis will be based on an objective ‘biomarker’ and not simply on the opinion of a clinician which is formed after an interview. Simply being diagnosed means patients can take the next steps to get help and improve their quality of life. People with autism are affected in different ways; some can lead relatively independent lives while others need specialist support or are so severely affected they cannot communicate their feelings and frustrations at all. Clearly the ethical implications of scanning people who may not suspect they have autism needs to be handled carefully and sensitively as this technique becomes part of clinical practice.”
 


Professor Christopher Kennard, Chair of the MRC’s Neuroscience and Mental Health funding board said:


“Bringing together the knowledge gained from neuroscience in the laboratory and careful clinical and neuropsychological evaluation in the clinic has been key to the success of this new diagnostic tool. In fact, this approach to research is a crucial theme throughout the MRC’s strategy. We know that an investment like this can dramatically affect the quality of life for patients and their families. The more we understand about the biological basis of autism, the better equipped we will be to find new ways of treating those affected in the future.”

The research studied 20 healthy adults, 20 adults with ASD, and 19 adults with ADHD. All participants were males aged between 20 and 68 years. After first being diagnosed by traditional methods (an IQ test, psychiatric interview, physical examination and blood test), scientists used the newly-developed brain scanning technique as a comparison. The brain scan was highly effective in identifying individuals with autism and may therefore provide a rapid diagnostic instrument, using biological signposts, to detect autism in the future.

The research was undertaken using the A.I.M.S. Consortium (Autism Imaging Multicentre Study), which is funded by the MRC. Support funding was also provided by the Wellcome Trust and National Institute for Health Research.

The paper, ‘Describing The Brain In Autism In Five Dimensions - MRI-Assisted Diagnosis Using A Multi-Parameter Classification Approach’ is published in the Journal of Neuroscience on Wednesday 11 August.




Tuesday, August 10, 2010

Mother Kills Her Autistic Child and Herself and Throwing Stones Will Not Bring Them Back

I didn't know Tracy Hawks, 47, of Howard County, Maryland who police say killed her  autistic and mildly  intellectually disabled son Christopher Melton on June 4 using a gas generator. ExploreHoward.com  says the mother suffered from depression and there had been a family breakup. The mother was described as being close to her son  Christopher who was described by several persons interviewed at the school he attended as a great kid, well behaved, caring and welcoming with a smile for anyone who looked at him.  

People will judge the mother and many, perhaps most,  will judge her harshly, very harshly.  I do not quarrel with those judgments. Those judgments though will not change the facts ... that the mother and her son are both gone.  The study has enough details to suggest that the son's disabilities may have had little to do with the mother's desperation. Readers like me have no way of knowing that with any certainty. 

What is certain though is that with better assistance from communities and governments,   with real  support and services, with the knowledge  that an autistic child will live a decent life after a parent has passed on,   some ... some ...  of these cases would turn out differently.  In some, not all, but some of these cases, a child with autism would live and perhaps enjoy life to the fullest.  Throwing stones at the dead parents will not, however, change a thing.

Monday, August 09, 2010

Autism Speaks Supports More Environmental Research? Terrific! Now Please Help Even Out the Funding


Right now, about 10 to 20 times more research dollars are spent on studies of the genetic causes of autism than on environmental ones.

We need to even out the funding.

Dr. Irva Hertz-Picciotto, UC Davis M.I.N.D. Institute


I have been a  supporter of Autism Speaks over the course of its brief existence. I appreciate the media savvy and political skills of its leadership. The World Autism Awareness Day that it assisted in bringing into existence is, in my humble opinion, a great accomplishment in itself.  The connections and skills of Autism Speaks leadership have been very impressive in bringing in people and events who, by themselves command attention, from NASCAR to Jerry Seinfeld, people and events that are seen and heard focusing on autism.  Well done, very well done.

I have though been concerned, rightly or wrongly, about  what I thought was a  subscription by Autism Speaks to the "it's gotta be genetic" mindset which has dominated autism research  and hindered  progress in understanding autism disorders and developing treatments and cures.   I was pleasantly surprised when I received from Jane Rubenstein of Rubenstein Communications Inc. the Autism Speaks statement  "HEARING ON STATE OF RESEARCH ON POTENTIAL ENVIRONMENTAL HEALTH FACTORS WITH AUTISM AND RELATED NEURODEVELOPMENT DISORDERS U.S. Senate Committee on Environment & Public Works, Subcommittee on Children’s Health".   In the statement Autism Speaks Chief Science Officer Dr. Geri Dawson states unequivocally Autism Speaks endorsement on the need for more environmentally based autism research:

(NEW YORK, N.Y., August 4, 2010) – Autism Speaks’ Chief Science Officer Geraldine Dawson, Ph.D. emphasized the importance of research on environmental risk factors for autism spectrum disorders as the U.S. Senate Committee on Environment & Public Works, Subcommittee on Children’s Health convened a special hearing yesterday on potential environmental health factors associated with autism spectrum disorders (ASD) and related neurodevelopmental disorders. The hearing examined the latest research on potential environmental factors that may increase the risk for autism spectrum disorders.

As this hearing reviewed studies funded by the Environmental Protection Agency and the National Institute of Environmental Health Sciences on environmental factors associated with autism, including toxins and other factors that can influence brain development, Dr. Dawson reiterated that it is important to remember that, “Although genetic factors clearly contribute to the causes of autism, we also need to understand environmental factors and their interactions with genetic susceptibility.”

Dr. Dawson's statement  includes examples of  what appear to be impressive  initiatives undertaken by Autism Speaks in support of environmental autism research.  The links to review these initiatives can be found on the Autism Speaks web site, science section.  What isn't clear is the level of financial commitment to environmental autism research compared to genetic research.  Does, or will, Autism Speaks commit to balanced funding of environmental and genetic autism research as called for by Dr. Irva Hertz-Picciotto of the UC David MIND Institute?

If I have wronged Autism Speaks with my perception of an imbalance on its part in favor of genetic over environmental autism research I would genuinely appreciate being notified of my error. If that is the case then I will apologize but would humbly and respectfully ask Autism Speaks to use its proven and impressive communication skills to convince public health funding authorities to follow the approach recommended by Dr. Hertz-Picciotto. 

Much valuable time has been lost with the autism is genetic obsession.

Balanced funding of environmental and genetic autism research is needed now, not tomorrow.

Sunday, August 08, 2010

Autism Paradigm Shift: Environmental and Genetic Factors Cause Autism Disorders


The important testimony before the US Senate last week was of monumental importance in placing on the record of such a high public tribunal the evidence of credible experts confirming what has been known by many for so long: autism disorders are caused by the interaction of genetic AND environmental factors.  Autism is NOT entirely genetic in origin. Environmental factors, long neglected in research funding, are involved and future autism research MUST reflect that fact. The overwhelming funding  imbalance to date in favor of genetic focused autism research MUST be shifted toward exploration of environmental causes of autism disorders. The Autism Research Paradigm Shift must now pick up speed so that we can find causes of, treatments and cures for, autism spectrum disorders.

The near total dedication of funding towards genetic autism research was outed by Teresa Binstock over a decade ago and today genetics has contributed little if anything to understanding or addressing autism challenges. For several years it has been known that environmental factors are in fact involved in curing autism and in 2007 the University of Minnesota proposed an Autism Research Paradigm Shift:


"Autism research is poised for another paradigm shift, from an irreversible condition to a treatable disease. In the revolutionary paradigm, autism is not a rare disorder with a constant rate but frequent condition with a rising incidence. It is a combination of environmental influence and genetic vulnerabilities. It is both preventable and treatable, not by any one method but by a combination of behavioral and biomedical approaches. Autistic kids are not defective, they are sick but otherwise normal kids, and thus, recoverable.

Creating a premier center for effective treatment of autism is not as simple as adding a new wing on a hospital, purchasing the latest medical technology or creating another diagnostic center. 
What is needed is a revolutionary clinical effort premised on the paradigm that autism may well be a treatable and preventable disease.


 The University of Minnesota proposal may have been ahead of its time and the proposed paradigm shift has probably been set back by the intensive effort to discredit those who question vaccines.  Major media sources have dutifully swallowed the reported  pharma line that autism is purely genetic, which, if believed , would preclude further blame being placed on vaccines or vaccine ingredients as causes or triggers of autism disorders in some children. It will undoubtedly take time for the NYT, the Chicago Tribune, the Globe and Mail, CNN and CBC to catch up to the autism research and internet communities but it is now clear that the future of autism research must include a much greater focus on environmental causes of autism.   And of course, if they continue to dutifully follow pharmaceutical industry press releases these august media may never catch up or catch on to new developments in our understanding of autism disorders.

There is at least one hopeful sign though. The offficial Autism Speaks press release commenting on the US Senate hearings adopted a fairly bold tone in calling for more emphasis on environmental factors and autism:

"As this hearing reviews studies funded by the Environmental Protection Agency and the National Institute of Environmental Health Sciences on environmental factors associated with autism, including toxins and other factors that can influence brain development, Dr. Dawson reiterated that it is important to remember that, "Although genetic factors clearly contribute to the causes of autism, we also need to understand environmental factors and their interactions with genetic susceptibility."

The dramatic increase in autism prevalence over the last decade – increasing 600 percent in the last two decades – underscores the need for more research on environmental factors. "Our understanding of typical brain development combined with what we've learned from examining the brains of individuals with autism indicates that it is important to investigate the roles of the prenatal and early postnatal environment," explains Dr. Dawson. "To investigate environmental factors that may be active during this time, researchers are casting a wide net on potential environmental agents that can alter neurodevelopment, including exposure to infection, pesticides, and chemicals."

If Autism Speaks dares speak so boldly perhaps the Autism Research Paradigm Shift envisioned by the University of Minnesota  is fully under way and perhaps we can now look forward to understanding the environmental causes of, and finding treatments and cures for,  autism disorders.

Friday, August 06, 2010

Autism Epidemic: Genetic Autism Myth Finally Busted at the US Senate

It's gotta be genetic?  The myth that autism is 100% genetic, that environment plays no part in causing autism, that there is no true autism epidemic took a severe, even fatal beating, this week in the US Senate.

Teresa Binstock exposed the mindset that directed funding almost exclusively towards genetic based autism research over a decade ago. Years later,  and with little to show for the nearly cult like belief that autism is,  that autism must be, that autism just has to be,  100% genetic,  and public autism research funding dollars still flow almost exclusively toward genetic based autism research. This one way flow  of research funding has prevented us from greater understanding of  the environmental factors that might be causing or triggering autism in  children's prenatal and neonatal development.   This week, in the Children's Health Subcommittee of the US Senate Senate Committee of Environment and Public Works,  the "autism is 100% genetic myth" was busted. Despite few research dollars flowing toward environmentally based autism research it is environmental factors that are beginning to provide some understanding of autism and other neurodevelopmental disorders.


1.  Paul Anastas Ph.D.

  Assistant Administrator for Research and Development and Science Advisor U.S. Environmental Protection Agency (EPA)

Dr. Anastas gave a very careful and conservative review of existing environmental research with implications for autism and other developmental disorders.  By way of background he noted:

"children are especially susceptible to the effects of chemicals in the environment because they eat, drink and breathe in more for their body weight than adults. They absorb a greater proportion of many chemicals in the environment than adults do, and due to hand to mouth behaviors, young children tend to have higher exposures to contaminants in dust and soil, such as pollutants deposited from the surrounding air, dust from lead paint, tobacco smoke, cleaning products, pesticides and other chemicals.3, 4 Because of its extraordinary complexity, prenatal and early postnatal brain and nervous system development can be disrupted by environmental exposures at much lower levels than would affect adults.5,6,7,8,9 We are learning that there are critical windows of susceptibility both prenatally and in early childhood, during which the effects of exposures to environmental contaminants, depending on dose and timing, can be significantly more severe and can lead to permanent and irreversible disability.10,11,12 For these and many other reasons, EPA is especially concerned about potential effects of environmental chemicals on children’s health and neurodevelopment.

It has been suggested that improvements in diagnosis may be contributing to the perceived increase in ASDs. However, one recent publication from researchers supported by EPA and the National Institute of Environmental Health Sciences (NIEHS) evaluated the rise in autism incidence in California from 1990 through 2006. They found that even when factors such as earlier diagnosis, changes in diagnostic criteria and inclusion of milder cases were taken into account, these did not fully explain the observed increase, and as a result the extent to which the continued rise represents a true increase in the occurrence of autism remains unclear.13 Additionally, through a recent evaluation of autistic disorder (AD) data from long-term (~ 10 years) studies , ORD scientists found significant and surprisingly uniform timing of increases in AD cumulative incidence (1988-1989) in Danish, California and worldwide data sets.14 It is not clear if the observed increase in AD is real, and if so, for what reason; or whether the apparent increase is due to improved diagnosis, increased observations, or other factors. However, these researchers concluded that it seems prudent to assume that at least some portion of the observed increase is real and results from environmental factors interacting with susceptible populations.14 Such exposures may be preventable; identification of candidate environmental factors should be a research priority.

The challenge is to determine what specific environmental factors may contribute to the onset or severity of autism and other neurodevelopmental disorders, so that exposure to these can be prevented."  

2. Linda Birnbaum, Ph.D., D.A.B.T., A.T.S. Director, National Institute of Environmental and Health Sciences and National Toxicology Program National Institutes of Health, United States Department of Health and Human Services

Dr. Birnbaum commented on the emerging emphasis on genetic and environmental interaction in understanding neurodevelopmental disorders:

"Scientists have made tremendous progress in understanding how the brain and nervous system grow and function. Research supported by NEIHS has clearly shown that it is not just genetics, but the complicated interplay of both genes and environment that determines the risk of many neurodevelopmental disorders. We now have new information on the role that early environmental exposures may play in the development of a broad spectrum of childhood and adult disorders, including autism, attention deficit hyperactivity disorder (ADHD), and learning disorders."
...

Development of the nervous system begins in the womb and extends through childhood. During these periods of rapid development, the brain is vulnerable to some environmental exposures that may have the potential to disrupt the chemical signals that organize development. Even small changes in the timing of critical development events can potentially have major consequences for brain structure and function. Thus even brief exposures at these vulnerable stages can have lasting effects on adult brain function. We refer to "windows of  susceptibility: to mean the life stage at which the brain is exposed, during which different agents can effect the brain in specific and deleterious ways. For example, the dose of lead that is neurotoxic to an infant is much less than the dose that would be neurotoxic for an adult, so infancy in this case is a "window of susceptibility",

Director Birnbaum commented specifically on the effect of environmental exposures on children's intelligence.  The "vast majority", to use the expression of CDC autism expert Dr. Yeargin-Allsopp,  of children with Autistic Disorder (which does not include Aspergers)  also have intellectual disabilities. I have photocopied Director Birnbaum's summary of the research on this important subject:


3, Issac N. Pessah Ph.D. Professor, Department of Molecular Biosciences, College of Veterinary Medicine, Director, UC Davis Children’s Center for Environmental Health and Disease Prevention University of California, Davis, Department of Molecular Biosciences

Dr. Pessah began his testimony before the subcommittee with a direct challenge to the view that diagnostic change is a full explanation for autism increases and that autism is 100% genetic:

"Although autism risk has strong heritability, no single locus alone appears to be sufficient to account for the full clinical phenotype. Results from many genomewide autism screens indicate that potential susceptibility genes are spread across the entire genome. Recently several very rare genetic mutations, single nucleotide polymorphisms (SNPs), de novo copy number variations, and epigenetic factors that influence DNA methylation were shown to contribute complexity in the transmission of autism risk. Yet genetics alone cannot account for the majority of autism cases currently being diagnosed. There is lack of full concordance between monozygotic twins, with some estimate ranging as low as 60%, and the prevalence of ASD among siblings has been reported as high as 14%. Interactions among multiple genes are likely to contribute to various types of autism, and heritable epigenetic factors and/or non-heritable environmental exposures are likely to significantly contribute to susceptibility and variable expression of autism and autism-related traits. It is therefore likely that constellations of epigenetic and environmental factors are contributing to the increasing prevalence of ASD, a rise that cannot be fully accounted for by changes in diagnostic criteria.

....

There is a critical need to identify environmental factors, including exposure to xenobiotic chemicals and changes in diet that contribute to autism risk and severity. The vast majority of public and private resources has, and continues, to support work on identifying genetic impairments associated with autism risk. From these studies we have learned that genetics alone cannot predict the majority of autism cases, the patterns of impairments, severity, nor can they predict success for current treatment modalities. Moreover, we have learned that many of the molecular and cellular systems that are associated with autism are the very same ones that are the target of environmental chemicals currently of concern to human health because of their widespread use.



..


We know that autism prevalence continues to increase dramatically clearly implicating environmental factors in autism risk. We must identify which environmental exposures and combination of exposures are contributing to increased overall risk in the population and identify the most susceptible groups. Only by bringing together the concerted effort of multidisciplinary teams of scientists can we identify which of the >80,000 commercially important chemicals currently in production promote developmental neurotoxicity consistent with the immunological and neurological impairments identified in individuals with idiopathic autism. It is clear that there is a critical need to identify which chemicals in the environment that influence the same biological pathways known to be affected in autism. Limiting exposure to these chemicals is the only way to mitigate or prevent autism in susceptible individuals.  (Bold emphasis added - HLD)

4. Bruce P. Lanphear MD, MPH Senior Scientist, Child & Family Research Institute, Professor, Simon Fraser University, Vancouver, BC, Adjunct Professor, Cincinnati Children's Hospital Medical Center

Dr. Lanphear 's prepared statement was relatively brief and to the point; and  the body of the statement is reproduced below with my empahsis in bold:


Children’s environmental health -- the study and prevention of disease and disabilities in children from exposures to social, physical, biologic, and chemical agents -- has emerged as a new field of research, policy, and clinical practice (Landrigan et al. 1998). The growth of this field has been fueled by the emergence of new morbidities in children, research showing that the fetus and child are particularly vulnerable to environmental influences, and mounting evidence implicating environmental exposures as major risk factors for prevalent diseases and disabilities in children (Lanphear, 2005).

One in six American children have a developmental problem, from a subtle learning disability to overt behavioral disorders, such as attention deficit hyperactivity disorder (ADHD) or autism (Boyle et al. 1994; Hertz-Picciotto, 2009). These conditions can severely impair a child’s ability to succeed in school, elevate their risk for violent and criminal behaviors, and dramatically diminish their ability to contribute to society. The findings from some of the most thoroughly studied and widely dispersed environmental toxicants indicate that exposure to exceedingly low levels are risk factors for the “new morbidities” of childhood -- intellectual impairments, behavioral problems, asthma and preterm birth (Lanphear, 2005). Indeed, there is often no apparent threshold and, in some cases the effects appear to be greater at the lowest levels of exposure (England et al. 2001; Canfield et al. 2003; Lanphear et al. 2005; Yolton et al. 2005).
Exposures to established environmental toxicants -- such as lead, tobacco, PCBs and mercury -- have consistently been linked with higher rates of intellectual impairment or behavioral problems, such as conduct disorder and ADHD (Needleman et al. 1990; Schantz et al. 2003; Kahn et al. 2003; Wakschlag et al. 2002; Stewart et al. 2003; Needleman et al. 1979; Lanphear et al. 2005; Yolton et al. 2005). There is emerging evidence that a whole host of new environmental chemicals – such as Bisphenol A, PBDEs, pesticides, phthalates, and airborne pollutants – are associated with intellectual deficits or behavioral problems in children, but the evidence is not as conclusive (Rauh, 2006; Engel, 2010; Eskenazi, 2007; Braun, 2009; Perera 2009; Herbstman, 2010). Much of this research was done by the NIEHS/US EPA Children’s Environmental Health Research Centers working collaboratively with the Centers for Disease Control and Prevention.

Children’s developing brains are more vulnerable to certain toxicants and pollutants than adults. The central nervous systems of the fetus and young child, which are undergoing rapid changes, are particularly vulnerable to some toxicants. The fetus is a recipient of toxicants through placental transfer (Perera et al. 2003; Whyatt and Perera 1995; Bearer 2003). In some cases, such as mercury, the fetus is exposed to a larger dose than the mother (Ramirez et al. 2000). In other cases, such as organophosphate pesticides, the fetus may lack critical enzymes to metabolize environmental toxicants (Chen et al. 2003). Toddlers are often at greater risk for exposure to many environmental toxicants because they have a high degree of hand-to-mouth activity and they absorb some toxicants more efficiently (Bearer 1995).




Biomarkers are revolutionizing our ability to study the impact of environmental chemicals on neurodevelopmental disabilities (Perera, 1997; Lanphear and Bearer 2005; CDC 2003; Sexton et al. 2004). Historically, scientists and clinicians relied on indirect markers -- housing condition, poverty, questionnaires, and community-level monitoring of water and air -- to quantify the effect of environmental influences on children’s health (Sexton et al. 2004). Biomarkers are making it possible to directly measure the internal dose for many environmental chemicals and test causal associations of environmental exposures with disease and disability in children.


I wanted to share some of the results of the Cincinnati Children’s Environmental Health Center to highlight the impact of low-level toxicity on children. In a 2003 study, published in the New England Journal of Medicine, we estimated that an increase in blood levels from <1 μg/dL to 10 μg/dL was associated with a 7 IQ point decrease (Canfield, 2003). Because of the policy implications, we convened an international group of experts to conduct a pooled analysis of seven cohort studies. We estimated that an increase in blood levels from <1 μg/dL to 10 μg/dL was associated with a 6 IQ point decrement (Lanphear, 2005). These studies have been confirmed by over ten studies conducted around the world.


We also confirmed earlier reports implicating childhood lead exposure in the epigenesis of psychopathology in children. We estimated that one in five cases of ADHD in US children were due to childhood lead exposure (Froehlich, 2009). We also found joint effects of prenatal tobacco exposure and childhood lead exposure. Although each toxicant was associated with a 2.5-fold elevated risk for ADHD, children with higher exposures to both toxicants had a 8-fold elevated risk for ADHD (Froehlich, 2009).


Finally, we confirmed that childhood lead exposure is a risk factor for criminal arrests in young adults. We found that lead exposure is associated with conduct disorder, criminal arrest and impaired brain development using magnetic brain imaging (Braun, 2008; Cecil 2008; Wright, 2008; Brubaker 2009). These and other studies suggest that much of the criminal and violent behaviors in the US can be attributed to lead toxicity (Nevin, 2000; Reyes, 2007). Gould used these studies to conduct a cost-benefit analysis of lead toxicity. She estimated that for every dollar spent to reduce lead exposure, society would benefit by $17 to $220, a net annual benefit of $30 billion to $44 billion (Gould, 2009).


Over the past century, increasing evidence has emerged linking chronic, low-level exposure to environmental influences and industrial pollutants with many of the most prevalent and disabling learning and behavioral problems in children. But questions remain. It is critical, for example, to examine the interactions of multiple environmental toxins or pollutants and to identify how genetic susceptibility or other markers of susceptibility elevate the risk for disease or disability. It is critical to discern whether the new chemicals are risk factors for autism and other emerging behavioral problems in children. Funding that is directed to children’s environmental health research – the Children’s Environmental Health Centers, the National Children’s Study and other research awards -- offers us the opportunity to resolve many of the unanswered questions and prevent some of the most serious problems that impact children’s learning abilities and behavioral problems, but much more needs to be done.

A parent Mary Moen also testified before the committee giving evidence familiar to many of us of the challenges  of raising a child with an autism disorder and an 48 year old family member, suspected of being autistic, who has lived dependent on the care of her aging parents.

The evidence of the experts who testified before the Children's Health Subcommittee of the US Senate Committee on Environment and Public Works have clearly busted the myth that autism, and other neurodevelopmental disorders are 100% genetic. They have presented studies of the known toxic substances including mercury, lead and various pollutants which we inhale, consume or are exposed to and the much harsher impact these substances have on prenatal and neonatal neurological development.  

It will take time for this information to permeate the public consciousness. The "it's gotta be genetic" mindset is too deeply entrenched in the culture of public health authorities in Canada and the US to change quickly. There are vested corporate interests for whom a 100% genetic theory of autism absolves them of any possible responsibility for harm caused by their products. There are traditional media sources hungry for corporate advertising dollars who will read the latest script offered up by the pharmaceutical marketing/research departments who will dutifully report that autism is 100% genetic and damn those crazy parents of autistic children who just can't accept that "fact"  and take responsibility for what our genes have done to our children.  The "it's gotta be genetic" mindset is also helped by the Neurodiversity ideologues for whom autism is just a natural variation, not a disorder to begin with, and who abhor any discussion of environmental causes of autism because, heaven forbid, the existence of known environmental triggers of autism might confirm that their DSM autism diagnosis is what it claims to be when  it was  obtained by visits to a qualified physician ...  a neurologically based mental disorder.

This is one case though where the truth, as it did with the tobacco and lung cancer issues of decades past, will out. The overwhelming commitment of research dollars to genetic based autism research has yielded very, very few results and has failed to identify common genetic bases for autism. That failure, and the  environmental research cited before the US Senate, which resulted from relatively limited research funding,  both point to environmental factors as triggers and causes of autism disorders in interaction with genetic factors.

The truth will out but it is long past time to even out the funding , as Dr. Irva Hertz-Picciotto has called for,  and direct some of the genetic based autism research dollars toward more environmentally focused autism research. The autism is 100% genetic myth is dead.  It is time to fully embrace the environmental genetic interaction model  of autism and find out how to help our  autistic children and children not yet born.

Thursday, August 05, 2010

Mainstream Media Autism Ignorance: Lovaas Passing, US Senate Hearings on Possible Environmental Causes of Autism Go Unmentioned

Many parents of autistic children do not look to the mainstream media (MSM)  for autism information.  For good reason. They are unlikely to learn anything about autism  from MSM sources.

Most of us learned long, long ago that the mainstream media focuses on feel good stories, Temple Grandin, Rainman, Sigourney Weaver, Clare Danes, and the latest  person with very high functioning autism or Aspergers  to declare that "WE" don't want to be cured, from Jim Sinclair, to Michelle Dawson, Amanda Baggs,  Alex Plank, JE Robison and of course the very well connected young university student Ari Ne'eman. The MSM love to report the Offit Script over and over that vaccines are beautiful and that an autism vaccine connection has been disproved for ever and ever after. The MSM dutifully reports that autism is genetic, that parents of autistic children  are emotional even hysterical, irrational and a danger to public health.

Amazingly, apart from a few local NBC outlets,  the passing of Dr. O. Ivar Lovaas, the man whose work and studies, had such great and positive impacts on the lives of autistic children, has gone unmentioned. So too, the U.S. Senate Committee on Environment & Public Works, Subcommittee on Children's Health which is examining  potential environmental factors of autism is also unreported in  the MSM. After decades of news reports on the genetic bases of autism high level US hearings on possible environmental causes of autism do not warrant any coverage by the MSM.

Of course it may not be the fault of the MSM. After all the MSM journalists may simply be ignorant of autism realities and over reliant on Hollywood and pharmaceutical industry press releases and the Offit  Script.  How could they  know anything of Lovaas or environmental factors of autism or appreciate the significance of either, particularly when it appears,  the marketing arms of  Hollywood and the pharmaceutical industry saw no advantage to  promoting either of  these important autism developments.

Wednesday, August 04, 2010

Dr. O. Ivar Lovaas, A True Friend of Autistic Children, Has Died

I love my son Conor dearly. Conor is severely autistic and intellectually disabled  and there is no greater compliment that I can  pay to Dr.  O. Ivar Lovaas than to say that he has helped  Conor to live a much more rewarding life than he otherwise would have known.

- Harold L Doherty, Conor's dad, on the passing of Dr. O. Ivar Lovaas


Video from MyNews4, NBC

Parents seeking help for their autistic children have few places to turn. There are people pushing various ideologies, there are professionals defending corporate interests, there are immature, self obsessed surgeons with no expertise in autism disorders insulting and berating parents of autistic children. there are many who declare that they know what is best for our autistic children.  But there are very few  who have stepped up to the plate and delivered any real help for autistic children and their families. One who did help, Dr.  O.Ivar  Lovaas, passed away yesterday.

My son Conor, now 14, did not benefit from the 40  hours a week of Applied Behavior Analysis, ABA,  between the ages of 2 to 5 as  indicated by the studies of Dr. Lovaas. The resources to provide such treatment were not easily available in New Brunswick 12 years ago and we did not even begin to know much about autism or how to deal with it for a couple of years. Here in New Brunswick a dedicated group of parents from Fredericton, Moncton, Miramichi and other communities fought against indifference and even hostility from well connected anti-ABA ideologues to help establish the UNB-CEL Autism Intervention Training program and ensure the provision of quality ABA services. Dr. Lovaas' work was of fundamental importance in discussions with government aimed at helping our autistic children.

Conor has benefited greatly from the provision of ABA based education intervention in our neighborhood schools. As a family,  ABA provided us with the tools to help us communicate with Conor who is severely autistic and intellectually disabled and otherwise has limited communication skills. 

Conor would not have received the benefits of ABA that he  has received and his life, and ours, would not be as rich as they are without the pioneering work of  Dr. O. Ivar Lovaas. 

Thank you Dr. Lovaas.

Tuesday, August 03, 2010

Whooda Thunk It? CNN: Study Raises Bias, Timely Disclosure Questions About Pharma Funded Drug Trials

Whooda Thunk It?

CNN reports that a recent study has disclosed evidence of bias in pharmaceutical company funded drug trials. The study found evidence of an inherent bias in favor of the drug being studies with such studies being 4 times more likely to report outcomes that favored the drug of the sponsoring pharmaceutical company. Industry funded drug trials were also less timely in providing public information about the trial results:

Researchers from the United States and Canada looked at 546 drug trials registered in ClinicalTrials.gov, a registry of both federal and private trials in the United States and abroad. 346 of them, or 63 percen, were funded by the drug industry. The remaining 200 were paid for by government or non-profit organizations. Study authors found that more than 85 percent of industry-funded trials in their sample posted favorable outcomes and were 4 times more likely to report findings that favored their drug.

"We did this study in order to determine whether there is an inherent bias because pharmaceutical companies fund trials on products in which they have a financial interest," said study co-author Dr. Kenneth Mandl of Children's Hospital, Boston. "The most reassuring result would have been that the rate of favorable outcomes would be the same regardless of funding sources. In a very dramatic way that was not the case and what we need to ascertain is if the cause of this shift toward favorable findings among trials funded by pharmaceutical companies is related to the details of the protocols and study design."

Dr. Florence Bourgeois, also of Children's Hospital, Boston and lead author of the study says typically trials sponsored by drug companies are more efficient and well funded. Still, she found the result stunning. "The implications of these findings are that we need more oversight in the way clinical trials are designed as well as in the analysis and reporting of the results. One option may be to make study protocols directly available on clinicatrials.gov as well as the comprehensive reviews complied by the FDA on trial results." She continued, "While we cannot specifically point to which factors contribute to the association between funding source and positive results reporting, our findings speak to the need for more disclosure of all elements of a study."

...

According to Mandl, industry funded trials also were less timely in terms of providing public information including trial results. He says even though drug trials are overseen by the Food and Drug Administration, there are still some variables that could favor pharmaceutical companies, including placebo comparisons, dosing and duration. "The concern is the pharmaceutical industry is funding the studies of the drugs in which they have a vested financial interest."

The influence of pharmaceutical companies in last years widely criticized H1N1 pandemic was examined by the Parliamentary Assembly of the Council of Europe (PACE). In its March 23 2010 report The handling of the H1N1 pandemic: more transparency needed the PACE expressed concern over the connections between World Health Organization (WHO) science advisors and pharmaceutical company interests:

11. Independent experts from the medical community mainly criticised the agenda setting and governance process concerning the H1N1 flu in terms of the criteria used for declaring a pandemic, the lack of empirical evidence justifying such a step and the clearance to use certain medicines and vaccines. They also repeatedly raised the issue of the influence that private stakeholders from the pharmaceutical industry might have had on major decisions taken by international and national authorities. For the purpose of this memorandum the rapporteur has compiled the main issues raised in a critical perspective. All arguments presented seem to have one common reference point: the disparity between the relatively mild unfolding of the influenza and the actions taken at European and national level.2

None of this, of course, is to suggest that there is any  unhealthy pharmaceutical company influence on public health authorities involved with autism issues ... right Dr. Gerberding?   Maybe Dr. Julie Gerberding, President of Merck Vaccines  can put to rest fears of pharma conflicts of interest by pushing for a comparative study of autism rates in vaccinated and unvaccinated populations as once called for by  former CDC  Director Dr. Julie Gerberding who once said that "such studies could be done and should be done".

Sunday, August 01, 2010

Vaccine Autism War Is Declared Over: Autism Is 100% Genetic, Vaccine Concerned Parents Are Fanatics

Dr. Henry Miller, physician and molecular biologist, a fellow at Stanford University's Hoover Institution, and Dr. Elizabeth Whelan, president of the American Council on Science and Health, have ended the vaccine autism wars. 

Without providing any fancy explanations, or any  substantial explanation at all, these learned figures have declared in Unlocking the Genetic Secrets of Autism  that autism is 100% genetic and parents who resist this knowledge are fanatics particularly those who believe vaccines may play a role in causing vaccines. There ain't much science or logic in the declaration to confuse fanatic parents. The war is over. Autism is genetic. Let the parades begin:

Intense and even fanatical resistance to vaccination against childhood diseases is itself a significant public health problem. Opponents have blamed vaccines for everything from allergies and diabetes to cancer and autism. A recent study of abnormalities in the DNA of children with autism spectrum disorders (ASDs) should finally put to rest the claims of some activists, mainly parents of affected children, that vaccines cause these conditions.